• Explore /
  • Poster
  • / Cyclin-dependent kinase 4/6 inhibition for the treatment of mature teratoma germ cell tumor: Long-term follow-up of a phase II study.

Cyclin-dependent kinase 4/6 inhibition for the treatment of mature teratoma germ cell tumor: Long-term follow-up of a phase II study.

Abstract Poster

Authors

Vivek Narayan

Vivek Narayan

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

Vivek Narayan , Wei-Ting Hwang , Priti Lal , Mark Alan Rosen , Maryann Gallagher , Peter J. O'Dwyer , David J. Vaughn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 474)

DOI

10.1200/jco.2016.34.2_suppl.474

Abstract #

474

Poster Bd #

K21

Abstract Disclosures

Similar Posters

First Author: Lei Liu

First Author: Stephen Joseph Bagley

First Author: Ayca Gucalp

Poster

2019 Genitourinary Cancers Symposium

A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression.

A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression.

First Author: Daniel E. Castellano